Work

Evaluation of Antidepressant Activity of Kalanchoe Pinnata in Mice

Year: 2026
Type: article
Abstract: Depression is a common and debilitating psychiatric disorder associated with significant morbidity and mortality worldwide. The limitations of currently available antidepressant drugs, including delayed onset and adverse effects, necessitate the exploration of alternative therapeutic agents, particularly from medicinal plants. The present study aimed to evaluate the antidepressant-like activity of aqueous (AEKP) and ethanolic (EEKP) extracts of Kalanchoe pinnata leaves using validated behavioral models in Swiss albino mice. Antidepressant activity was assessed using the Tail Suspension Test (TST) and Forced Swim Test (FST). Mice were treated with AEKP and EEKP at doses of 250 and 500 mg/kg (p.o.), and their effects were compared with the standard drug fluoxetine (10 mg/kg). In the TST, both extracts produced a significant (p < 0.05–0.001) and dose-dependent reduction in immobility time compared to the control group. Similarly, in the FST, treatment with the extracts significantly decreased immobility duration and increased active behaviors (number of jumps), indicating antidepressant-like effects. The ethanolic extract exhibited comparatively greater efficacy than the aqueous extract, particularly at higher doses, and its effects were comparable to those of fluoxetine. The observed activity may be attributed to the presence of bioactive phytoconstituents such as flavonoids, alkaloids, and glycosides, which are known to modulate monoaminergic neurotransmission. In conclusion, the findings suggest that Kalanchoe pinnata possesses significant antidepressant-like activity and may serve as a potential natural therapeutic agent for the management of depression. Further studies are required to elucidate the exact mechanism of action and to isolate the active constituents.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7225856519
FWCI:
Cites:
Cited by:
Related to: 10